Hangzhou Coco Healthcare Products Co.,Ltd.

Symbol: 301009.SZ

SHZ

9.21

CNY

Market price today

  • -69.9662

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 2.50B

    MRK Cap

  • 0.00%

    DIV Yield

Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) Stock Price & Analysis

Shares Outstanding

271.86M

Gross Profit Margin

0.17%

Operating Profit Margin

-0.03%

Net Profit Margin

-0.03%

Return on Assets

-0.02%

Return on Equity

-0.02%

Return on Capital Employed

-0.02%

Company general description and statistics

Sector: Consumer Defensive
Industry: Household & Personal Products
CEO:Mr. Liwei Jin
Full-time employees:685
City:Hangzhou
Address:Chengxi Industrial Park
IPO:2021-06-17
CIK:

Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as absorbent towels and absorbent pads for men. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.

General Outlook

In simple terms, Hangzhou Coco Healthcare Products Co.,Ltd. has 271.86 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.174% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.033%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.027%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.016% return, is a testament to Hangzhou Coco Healthcare Products Co.,Ltd.'s adeptness in optimizing resource deployment. Hangzhou Coco Healthcare Products Co.,Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.022%. Furthermore, the proficiency of Hangzhou Coco Healthcare Products Co.,Ltd. in capital utilization is underscored by a remarkable -0.025% return on capital employed.

Stock Prices

Hangzhou Coco Healthcare Products Co.,Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $9.12, while its low point bottomed out at $8.89. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Hangzhou Coco Healthcare Products Co.,Ltd.'s stock market.

Liquidity Ratios

Analyzing 301009.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 263.11% gauges short-term asset coverage for liabilities. The quick ratio (231.40%) assesses immediate liquidity, while the cash ratio (182.96%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio263.11%
Quick Ratio231.40%
Cash Ratio182.96%

Profitability Ratios

301009.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -3.42% underscores its earnings before tax deductions. The effective tax rate stands at -10.69%, revealing its tax efficiency. The net income per EBT, 78.43%, and the EBT per EBIT, 104.40%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -3.28%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-3.42%
Effective Tax Rate-10.69%
Net Income per EBT78.43%
EBT per EBIT104.40%
EBIT per Revenue-3.28%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.63, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 491.81% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding231
Days of Inventory Outstanding42
Operating Cycle116.00
Days of Payables Outstanding149
Cash Conversion Cycle-33
Receivables Turnover4.92
Payables Turnover2.45
Inventory Turnover8.74
Fixed Asset Turnover1.69
Asset Turnover0.59

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.51, and free cash flow per share, 0.25, depict cash generation on a per-share basis. The cash per share value, 2.86, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.12, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.51
Free Cash Flow per Share0.25
Cash per Share2.86
Operating Cash Flow Sales Ratio0.12
Free Cash Flow to Operating Cash Flow Ratio0.48
Cash Flow Coverage Ratio7.28
Short Term Coverage Ratio21.45
Capital Expenditure Coverage Ratio1.94
Dividend Paid and Capex Coverage Ratio1.94
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.97%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.01, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.90%, and total debt to capitalization, 1.35%, ratios shed light on its capital structure. An interest coverage of -71.38 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.97%
Debt Equity Ratio0.01
Long Term Debt to Capitalization0.90%
Total Debt to Capitalization1.35%
Interest Coverage-71.38
Cash Flow to Debt Ratio7.28
Company Equity Multiplier1.42

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.36, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.16, reflects the portion of profit attributed to each share. The book value per share, 4.98, represents the net asset value distributed per share, while the tangible book value per share, 4.95, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.36
Net Income Per Share-0.16
Book Value Per Share4.98
Tangible Book Value Per Share4.95
Shareholders Equity Per Share4.98
Interest Debt Per Share0.02
Capex Per Share-0.43

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -0.01%, indicates top-line expansion, while the gross profit growth, -29.72%, reveals profitability trends. EBIT growth, -222.44%, and operating income growth, -222.44%, offer insights into operational profitability progression. The net income growth, -208.51%, showcases bottom-line expansion, and the EPS growth, -194.12%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-0.01%
Gross Profit Growth-29.72%
EBIT Growth-222.44%
Operating Income Growth-222.44%
Net Income Growth-208.51%
EPS Growth-194.12%
EPS Diluted Growth-194.12%
Weighted Average Shares Growth15.29%
Weighted Average Shares Diluted Growth15.29%
Dividends per Share Growth1769.95%
Operating Cash Flow Growth-173.63%
Free Cash Flow Growth19.12%
10-Year Revenue Growth per Share11.47%
5-Year Revenue Growth per Share11.47%
3-Year Revenue Growth per Share-25.48%
10-Year Operating CF Growth per Share-125.07%
5-Year Operating CF Growth per Share-125.07%
3-Year Operating CF Growth per Share-112.28%
10-Year Net Income Growth per Share-176.19%
5-Year Net Income Growth per Share-176.19%
3-Year Net Income Growth per Share-136.36%
10-Year Shareholders Equity Growth per Share132.07%
5-Year Shareholders Equity Growth per Share132.07%
3-Year Shareholders Equity Growth per Share149.94%
10-Year Dividend per Share Growth per Share-69.81%
5-Year Dividend per Share Growth per Share-69.81%
3-Year Dividend per Share Growth per Share-92.23%
Receivables Growth45.83%
Inventory Growth18.49%
Asset Growth-6.57%
Book Value per Share Growth-17.08%
Debt Growth-29.76%
R&D Expense Growth3.47%
SGA Expenses Growth-0.03%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,577,496,812, captures the company's total value, considering both debt and equity. Income quality, 0.66, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 4.30%, highlights investment in innovation. The ratio of intangibles to total assets, 4.35%, indicates the value of non-physical assets, and capex to operating cash flow, 312.87%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value2,577,496,812
Income Quality0.66
Sales General and Administrative to Revenue0.01
Research and Development to Revenue4.30%
Intangibles to Total Assets4.35%
Capex to Operating Cash Flow312.87%
Capex to Revenue-9.81%
Capex to Depreciation-190.03%
Stock-Based Compensation to Revenue0.52%
Graham Number4.21
Return on Tangible Assets-2.31%
Graham Net Net1.65
Working Capital683,990,729
Tangible Asset Value1,346,895,708
Net Current Asset Value641,651,742
Average Receivables231,339,264.5
Average Payables479,189,210
Average Inventory168,181,085.5
Days Sales Outstanding84
Days Payables Outstanding152
Days of Inventory On Hand65
ROIC-4.08%
ROE-0.03%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.56, and the price to book ratio, 1.56, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.88, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 32.19, and price to operating cash flows, 15.58, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.56
Price to Book Ratio1.56
Price to Sales Ratio1.88
Price Cash Flow Ratio15.58
Enterprise Value Multiple62.91
Price Fair Value1.56
Price to Operating Cash Flow Ratio15.58
Price to Free Cash Flows Ratio32.19
Price to Tangible Book Ratio2.41
Enterprise Value to Sales2.17
Enterprise Value Over EBITDA30.79
EV to Operating Cash Flow-69.28
Earnings Yield-1.32%
Free Cash Flow Yield-4.71%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -69.966 in 2024.

What is the ticker symbol of Hangzhou Coco Healthcare Products Co.,Ltd. stock?

The ticker symbol of Hangzhou Coco Healthcare Products Co.,Ltd. stock is 301009.SZ.

What is company IPO date?

IPO date of Hangzhou Coco Healthcare Products Co.,Ltd. is 2021-06-17.

What is company current share price?

Current share price is 9.210 CNY.

What is stock market cap today?

The market cap of stock today is 2503830600.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 685.